,outcome,arm 1,arm 2
0,intervention,risperidone,placebo group
0,categorized as responders,8 ( 57 % ) of 14 patients,none of 16
0,"categorized as responders, total study group",2.9+/-1.4 mg,2.9+/-1.4 mg
